A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data ...

Researchers have developed a handheld, sound-based diagnostic system able to deliver precise results in an hour with a mere finger-prick of blood.

A look into ways AI technology in cardiology is evolving & how it can be applied to patient management & care as it continues ...

HeartBeam (NASDAQ: BEAT) has appointed Robert Eno as its new chief executive officer, effective Oct. 21, 2024. Eno, who joined the company as ...

A new study, conducted by a group of researchers led by Penn Nursing and Perelman School of Medicine found a strong ...

Charge your iPhone, Apple Watch, and AirPods wirelessly or via a fast USB-C port with this updated combo power bank and ...

HeartBeam (Nasdaq:BEAT) announced today that it appointed Robert Eno as its new CEO, effective Monday, Oct. 21, 2024.

As part of the long-planned transition, Branislav Vajdic, Ph.D., Founder and current CEO, will move into the role of President. In this role, Dr. Vajdic will focus on further innovating on the Company ...

The global cardiac ambulatory monitoring market, valued at USD 13.3 billion in 2021, is set for substantial growth, with a ...

Optune Lua creates tumor treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for concurrent use with PD-1/PD-L1 inhibitors or docetaxel, for the treatment of adult ...

People with Type 1 diabetes can connect their Dexcom blood-glucose sensor — an FDA-approved medical device — directly to their Apple Watch. This allows them to see their blood sugar in real-time, ...